B細胞性慢性リンパ性白血病に対する抗体薬の臨床開発 : alemtuzumabとofatumumab (特集血液腫瘍に対して開発中の注目すべき新薬)

B細胞性慢性リンパ性白血病に対する抗体薬の臨床開発 : alemtuzumabとofatumumab

(特集血液腫瘍に対して開発中の注目すべき新薬)

This page shows libraries in Japan other than the National Diet Library that hold the material.

Please contact your local library for information on how to use materials or whether it is possible to request materials from the holding libraries.

other

CiNii Research
Search Service
You can check the holdings of institutions and databases with which CiNii Research is linked at the site of CiNii Research.
Check the holdings of this book

You can check the details of this material, its authority (keywords that refer to materials on the same subject, author's name, etc.), etc.

Material Type: 記事
Title: B細胞性慢性リンパ性白血病に対する抗体薬の臨床開発 : alemtuzumabとofatumumab
Author/Editor: 福原傑
飛内賢正
Series Title: 特集血液腫瘍に対して開発中の注目すべき新薬
Author Heading: 福原傑
飛内賢正
Alternative Title: New agent in B-CLL : alemtuzumab and ofatumumab
Periodical title: 血液内科 = Hematology / 血液内科編集委員会編
No. or year of volume/issue: 66(1)=415:2013.1
Volume: 66
Issue: 1
Sequential issue number: 415
Pages: 26-32
Publication date of volume/issue (W3CDTF): 2013-01
ISSN (Periodical Title): 2185-582X
ISSN-L (Periodical Title): 2185-582X
Publication (Periodical Title): 東京 : 科学評論社
Place of Publication (Country Code): JP
Text Language Code: jpn
Subject Heading: B-chronic lymphocytic leukemia(B-CLL)
alemtuzumab
ofatumumab
NDLC: ZS21
Target Audience: 一般
Holding library: 国立国会図書館
Call No.: Z19-585
Data Provider (Database): 国立国会図書館 : 国立国会図書館雑誌記事索引
https://ndlsearch.ndl.go.jp
Bibliographic ID (NDL): 024269393
http://id.ndl.go.jp/bib/024269393
Bibliographic Record Category (NDL): 632